Björn Erik Anton Holm

Björn Erik Anton Holm is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on amido heteroaromatic compounds. His research focuses on the development of compounds that can be used in the treatment of various diseases.

Latest Patents

Holm holds a patent for amido heteroaromatic compounds, which includes pharmaceutically acceptable salts and processes for their preparation. This patent is crucial for the development of pharmaceutical compositions aimed at treating liver diseases. His work in this area demonstrates his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Holm is associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to collaborate with other experts in the field and contribute to groundbreaking research and development efforts. His patent reflects his expertise and dedication to innovation in pharmaceutical chemistry.

Collaborations

Holm has worked alongside talented colleagues such as Daniel Tor Pettersen and Stéphanie Marcelle Gueret. These collaborations have further enhanced his research capabilities and have led to significant advancements in the field.

Conclusion

Björn Erik Anton Holm is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of liver diseases significantly. His contributions through patents and collaborations highlight his role as a key figure in the industry.

Profile summary based on public USPTO records.